Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Plavinik et al., 1992
No Canadian province lists Wegovy on its standard drug formulary as of 2026
Its designed to help people stay consistent and feel supported
Individual tolerability varies significantly and requires close clinical follow-up
The main safety concern is QTc prolongation, particularly at higher doses or in combination with other QT-prolonging medications
Of note, incidence of MTC was extremely low in all of the large cardiovascular outcome trials with no significant increase seen in GLP-1RA-treated individuals, although it should be highlighted that some of the trials did have a family history of MEN-2 as an exclusion criterion
US$ 23.76
US$ 23.72
US$ 25.97
